ipscell.com
Will stem cell clinic Celltex reinvent itself after game-changing FDA warning letter? - The Niche
The FDA warning letter that Celltex received in late September (but that just went public yesterday–see my initial reaction here) is a possible game-changer for that company in my opinion. Why? The letter outlined in great detail the FDA’s concerns with how Celltex manufactures its stem cell product ranging from lack of documentation to concerns about aseptic/sterile … Will stem cell clinic Celltex reinvent itself after game-changing FDA warning letter? Read More »
Professor Paul Knoepfler, Ph.D.